Conestoga Capital Advisors’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,595,627
Closed -$45.2M 133
2024
Q1
$45.2M Buy
5,595,627
+74,490
+1% +$659K 0.65% 43
2023
Q4
$54.9M Buy
5,521,137
+595,280
+12% +$4.67M 0.82% 45
2023
Q3
$39.4M Sell
4,925,857
-522,246
-10% -$5.25M 0.68% 45
2023
Q2
$59.9M Sell
5,448,103
-10,500
-0.2% -$108K 0.95% 42
2023
Q1
$56.4M Buy
5,458,603
+1,988,939
+57% +$23.4M 0.94% 43
2022
Q4
$38.1M Buy
3,469,664
+598,892
+21% +$7.7M 0.71% 45
2022
Q3
$44.6M Sell
2,870,772
-668,083
-19% -$14.7M 0.87% 44
2022
Q2
$81.1M Buy
3,538,855
+4,995
+0.1% +$107K 1.48% 34
2022
Q1
$87.1M Buy
3,533,860
+1,574,237
+80% +$35.5M 1.31% 38
2021
Q4
$53.6M Buy
1,959,623
+1,859,350
+1,854% +$65M 0.7% 45
2021
Q3
$4.29M Buy
+100,273
New +$4.45M 0.06% 73

Other funds holding DH

Conestoga Capital Advisors's DH Position: Q2 2024 in Review

Conestoga Capital Advisors sold out of Definitive Healthcare (DH) in Q2 2024, closing a stake of 5,595,627 shares — an estimated $45.2M sold.

Conestoga Capital Advisors first reported a position in DH in Q3 2021 and held it in 11 quarters. The position peaked at $87.1M in Q1 2022. 143 funds tracked by Wall St. Rank hold DH as of Q2 2024.

  • Conestoga Capital Advisors reported no remaining Definitive Healthcare position as of Q2 2024 after selling out during the quarter.
  • Conestoga Capital Advisors sold 5,595,627 Definitive Healthcare shares in Q2 2024, an estimated $45.2M.
  • Conestoga Capital Advisors first reported a position in Definitive Healthcare in Q3 2021 and held it in 11 quarters.
  • Conestoga Capital Advisors's Definitive Healthcare position peaked at $87.1M in Q1 2022.
  • 143 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2024.

Based on Conestoga Capital Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.